Overactive bladder: a clinical entity or a marketing hype?
Madersbacher
Helmut
H
D018680:Cholinergic Antagonists / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D008389:Marketing of Health Services / Q000379:methods; D013577:Syndrome; D009626:Terminology as Topic; D014549:Urinary Incontinence / Q000175:diagnosis* / Q000188:drug therapy*; D014572:Urology / Q000379:methods*
D018680:Cholinergic Antagonists